If you built a business on hemp-derived cannabinoids, the ground under it is moving. A federal redefinition of hemp is scheduled to take effect this November, and by most industry estimates it removes the majority of hemp cannabinoid products from the legal market. Congress has spent the year arguing about the date. Meanwhile, the operators who will still be selling something in 2028 are the ones treating the hemp to cannabis transition as a licensing project rather than a lobbying outcome. This guide covers what actually changes, the four realistic paths in front of you, what parts of your existing business carry over into a licensed cannabis operation, and what to do in the next ninety days.
Running a hemp business and unsure what November means for you? We will map your product lines, your state, and your capital position against the licensed pathways actually open to you.
Talk to Our TeamWhat's in this guide
- What actually changes under the new hemp definition
- Where the deadline stands right now
- Your four realistic paths
- What transfers from hemp — and what doesn't
- The revenue gap nobody models
- States that built a transition pathway
- Capital, 280E, and structure
- Suitability and disclosure
- The next ninety days
- Five mistakes we keep seeing
- How Cannaspire helps
- Frequently asked questions
What actually changes under the new hemp definition
Start with the statute, because most of what circulates about it online is either compressed to the point of being wrong or written by someone selling inventory before a deadline.
On November 12, 2025, the full-year FY2026 agriculture appropriations act — P.L. 119-37 — was signed into law with a provision, Section 781, rewriting the federal definition of hemp. The change carries a one-year delay, which is what puts the effective date at November 12, 2026. Three pieces of it matter to an operator.
| Change | Old Standard | New Standard |
|---|---|---|
| How THC is measured | Delta-9 THC only, 0.3% by dry weight | Total THC — delta-9 plus 0.877 × THCA — at 0.3% by dry weight |
| Finished product ceiling | No per-container limit | 0.4 mg total THC per container |
| Cannabinoid source | Derivatives, isomers, and acids broadly included | Excludes cannabinoids not capable of being naturally produced by the plant, and those synthesized outside it |
The per-container cap is the provision that does the damage. "Container" is defined in the statute as the innermost wrapping or vessel in direct contact with the product as sold at retail — a jar, bottle, bag, box, packet, can, carton, or cartridge. At 0.4 milligrams of total THC across that entire container, a single conventional 5 mg gummy fails. Industry attorneys have put the share of hemp extract products currently on shelves that exceed the threshold at roughly 95%, and that estimate reaches well past intoxicating products into full-spectrum CBD tinctures that were never marketed for a high.
Two categories are not swept up. Industrial hemp grown for fiber, grain, and other non-cannabinoid uses stays protected. And genuinely non-detect or broad-spectrum formulations can be engineered under the cap, which is why some of the surviving businesses will be reformulation stories rather than licensing stories.
The rules are still incomplete. Section 781 directed the FDA to publish, within 90 days of enactment, lists of naturally occurring cannabinoids, THC-class cannabinoids, and other cannabinoids with similar effects — plus added specificity on what counts as a "container." That deadline was February 10, 2026. The agency missed it, and as of early August 2026 the lists remain unpublished. The Congressional Research Service flagged the absence in a report earlier this year. In practice that means the enforcement reference documents for a law taking effect in November do not exist yet, and the reading of "container" that decides whether a 30-count softgel bottle is compliant is still an open question.
Where the deadline stands right now
This section will age faster than the rest of the article. As of publication, here is the honest state of play.
The November 12 date is still the operative one. Hemp cannabinoid products above the 0.4 mg per-container threshold are scheduled to become controlled substances on that date. Nothing has changed that.
What has happened is a partial reprieve that is not yet law. In the early hours of Saturday, August 8, 2026, the Senate passed a funding bill containing language that would push the redefinition into December. A separate motion to strip that language out failed, 61 to 32. The Senate then left for a five-week recess. The House does not return until August 31, and until the House acts and the President signs, the delay is a Senate position rather than a change in the law.
The lobbying picture is genuinely two-sided, which is part of why the outcome is hard to call. Hemp advocates have picked up support from the alcohol distribution and retail lobby, which sees hemp beverages as a revenue line worth defending, and from lawmakers in states like Minnesota where hemp THC drinks are sold in liquor stores and mainstream grocery. On the other side, the state-licensed cannabis industry is lobbying to keep the ban intact, arguing that unregulated and synthetic products should not survive the loophole's closure. Separately, a bipartisan bill introduced in July by Representatives Andy Barr and Angie Craig would replace the ban with a federal regulatory framework — raising the marijuana threshold to 1% THC, banning synthetics, requiring domestic sourcing, imposing 21-plus age limits, and taxing hemp THC at five cents per milligram in beverages and 5% of retail price on other consumables. Several delay and repeal bills have also been filed. As of early August, none had advanced past committee.
How to plan against this. A thirty-day extension does not change a business model; it changes a shipping schedule. Even in the most favorable version — Congress passes a Barr-Craig-style framework — the result is federal regulation with age limits, potency caps, synthetic bans, domestic sourcing requirements, and a new excise tax. That is a licensed, taxed, compliance-heavy market. The set of skills it demands looks far more like cannabis than like 2019 hemp. Plan for the regulated outcome regardless of which vehicle delivers it.
Your four realistic paths
Operators tend to arrive at this decision late and then treat it as binary — get a cannabis license or shut down. There are four viable directions, and three of them do not require winning a competitive application.
| Path | What It Looks Like | Best Fit |
|---|---|---|
| 1. Reformulate and stay in hemp | Re-engineer the catalog under the total-THC and per-container tests. Functional cannabinoids, non-detect formulations, topicals, beverages built to whatever cap survives | Brands with real formulation capability, contract manufacturing relationships, and margin that survives lower potency |
| 2. Apply for a state cannabis license | Compete for cultivation, manufacturing, retail, or microbusiness licensure in a state where a window is open or opening | Operators with capital, real estate, local support, and 12 to 30 months of runway before revenue |
| 3. Become a supplier to the licensed market | Sell into cannabis licensees rather than to consumers — white-label manufacturing, extraction, packaging, testing, logistics, ancillary services | Businesses whose real asset is production capability or equipment rather than a consumer brand |
| 4. Sell, merge, or license the brand | Exit to a licensed operator, contribute assets into a licensed entity, or license brand IP to a cannabis licensee for a royalty | Strong consumer brands without the capital or appetite for a licensing cycle |
Path four is the one most under-considered, and the window on it is closing rather than opening. A hemp brand with distribution, a following, and clean books is worth more to a licensed multi-state operator in the third quarter of 2026 than it will be in the first quarter of 2027, when the same brand has no legal channel and no revenue. If an exit is even plausible for you, valuation work belongs on the calendar now, not after the shelf clears.
Path three deserves a similar second look. Licensed cannabis operators need extraction, co-packing, analytical testing, and compliant packaging, and many of them are buying those services from vendors with worse equipment and thinner process documentation than an established hemp manufacturer already has. Moving from a consumer brand to a business-to-business supplier is a smaller leap than moving from unlicensed to licensed.
What transfers from hemp — and what doesn't
The most expensive assumption in this transition is that a decade of hemp operating experience reads as cannabis experience to a licensing authority. Some of it does. A surprising amount of it does not, and the gaps are usually in exactly the areas that get scored.
| Asset | Transfers? | What to Know |
|---|---|---|
| Cultivation and extraction know-how | Largely yes | Genetics, growing, and extraction skills carry over well. Note that the new federal definition also restricts interstate movement of most cannabis genetics, which affects seed and clone sourcing |
| Facility and equipment | Partly | Extraction and packaging equipment usually transfers. The building often does not — cannabis licensure brings buffer distances, zoning conditions, and security specifications hemp facilities were never built to |
| Brand and customer list | Partly | Brand equity transfers; the direct-to-consumer channel usually does not. Most states prohibit interstate shipment and require in-state licensed retail. Packaging and marketing claims face far stricter review |
| SOPs and quality systems | Rarely as-is | Hemp SOPs are typically written to food-safety or general GMP expectations. Cannabis SOPs must map to a specific state's regulations, seed-to-sale system, and inspection checklist. Expect a rewrite, not an edit |
| Seed-to-sale tracking | No | Most hemp operations have never run Metrc, BioTrack, or an equivalent. This is a new operational discipline with real inspection consequences |
| Testing relationships | Partly | Your hemp lab may not be licensed for cannabis compliance testing in your state. Panels, sampling protocols, and chain-of-custody requirements are stricter |
| Banking and payments | No | Hemp businesses often hold ordinary merchant accounts and bank relationships. Plant-touching cannabis operators generally do not. Budget for cannabis-specific banking and cash handling |
Two lines on that table cause most of the trouble. The first is documentation: a hemp operator who has run a clean business for eight years often has that quality living in people's heads and in email threads rather than in a controlled document set, and a licensing application is scored on the document set. The second is real estate. We regularly see operators anchor an application to a building they already own or lease, only to find the site fails a school buffer or a locality's zoning overlay. Confirming site eligibility is a two-week exercise that saves months.
Need your SOPs and quality systems rebuilt to a state's standard? We convert hemp documentation into cannabis-ready SOPs, quality manuals, and audit-defensible records.
GMP & Quality SystemsThe revenue gap nobody models
Here is the structural problem that sinks otherwise sound transition plans: in most states, the date your hemp revenue stops and the date your cannabis revenue starts are not the same date, and the distance between them is measured in quarters.
Virginia is the clearest example. On August 15, 2026, the Commonwealth eliminates the 25:1 CBD-to-THC ratio allowance that let hemp products exceed 2 milligrams of total THC per package. After that date, a product carrying more than 2 milligrams of total THC per package cannot be produced or sold as a hemp product in Virginia. Regulated retail cannabis sales, meanwhile, do not begin until July 1, 2027, with the Cannabis Control Authority required to adopt regulations by February 1, 2027. That is roughly eleven months during which a large share of a Virginia hemp retailer's catalog has no legal channel and no licensed dispensary system to absorb it. Oversight of regulated hemp products is also moving from the Department of Agriculture and Consumer Services to the CCA during August 2026, so the agency reviewing your compliance is changing at the same moment your product standard does. Our Virginia cannabis consulting practice tracks the license types and timelines as the CCA publishes them.
The same shape appears elsewhere with different numbers. Ohio tightened intoxicating hemp rules under Senate Bill 56. California has confined hemp-derived THC to licensed cannabis retail. Texas has been regulating by agency rule amid active litigation, with the practical status of some categories shifting more than once this year. Tennessee moved hemp oversight to its alcoholic beverage regulator. Each of these creates a window where the old revenue is gone and the new revenue has not arrived.
Model the gap explicitly. Build a month-by-month cash forecast from your state's hemp cutoff to your realistic first cannabis revenue, and be honest about the second date — it is licensure plus buildout plus inspection, not licensure. Then decide how the gap gets funded: reformulated hemp revenue, business-to-business supply work, asset sales, or outside capital. Operators who fund the gap deliberately survive it. Operators who discover it in month three do not.
States that built a transition pathway
A handful of states have written the hemp-to-cannabis handoff into law rather than leaving operators to fall off a cliff. If you have any flexibility about where you operate, these are worth studying closely.
Minnesota has gone furthest. Its 2026 cannabis omnibus, SF 4401, removed the prohibition on holding both a hemp and a cannabis license, allowing dual licensure and permitting hemp and cannabis businesses to occupy the same premises where they share the same majority owner. The Office of Cannabis Management began taking applications under the new structure as the provisions took effect on August 1, 2026. The same bill created a "ratio hemp-infused cannabis product" category with defined cannabinoid limits, which gives a lower-potency product line a legal home inside the cannabis system. The framework was written with the federal November date explicitly in view — it is a bridge, not a coincidence. Our Minnesota cannabis consulting practice covers the license types and current windows in detail.
Other states are worth watching for different reasons. Virginia is folding hemp oversight into the same authority that will license cannabis, which at least puts one regulator in charge of both sides of an operator's file. New York has continued to expand licensed retail channels. Several states have created microbusiness or craft tiers with lower capital thresholds that are a more realistic entry point for a hemp company than a full vertical license.
Do not assume a pathway exists where one has not been legislated. Dual licensure, co-location, and conversion rights are specific statutory grants. Most states have not made them. In the majority of markets, a hemp operator applying for a cannabis license is a new applicant competing on the published rubric with no credit for hemp tenure — and in a few states, prior sale of intoxicating hemp is treated as a negative rather than a neutral fact. Verify your state's actual posture before building a plan around a pathway you read about somewhere else.
The application window is the constraint, not the deadline
Cannabis licensing windows open on the state's schedule, not yours. Missing one can mean waiting a year or more for the next round. We map open and upcoming windows against your capital, your site, and your product lines — and tell you plainly when the right move is to skip a round.
See Our Licensing ServicesCapital, 280E, and structure
The financial mechanics of a licensed cannabis business differ from a hemp business in ways that reshape the whole model, and they need to be in the pro forma before anyone signs anything.
| Factor | What Changes |
|---|---|
| Section 280E | Hemp businesses deduct ordinary business expenses normally. Plant-touching cannabis operators have historically been denied those deductions federally. The April 2026 rescheduling order moved state-licensed medical marijuana to Schedule III, taking it outside 280E, but adult-use cannabis remains Schedule I and 280E continues to apply to it. Some states have decoupled on their own returns — Virginia among them |
| Cost of capital | Expect higher rates, shorter terms, and more personal guarantees than a hemp business is used to. Traditional lenders are still largely absent from plant-touching operations |
| Application and license fees | Non-refundable application fees, license fees, and in some states escrowed capital requirements or proof of funds. These are sunk costs whether or not you win |
| Ownership limits and disclosure | Caps on how many licenses one entity may hold, residency preferences in some states, and full disclosure of every owner above a threshold — including passive investors from the hemp side |
| Social equity or impact eligibility | Many states reserve licenses or scoring advantages for qualifying applicants. Eligibility is fact-specific and needs to be assessed before the ownership structure is set, not after |
The 280E line is the one that changes decisions. A hemp operator moving into adult-use cannabis should assume federal deduction disallowance in the base case and treat any broader rescheduling as upside. Where state-level decoupling exists, it can matter substantially — Virginia's framework, for example, allows licensed cannabis businesses to deduct ordinary and necessary business expenses on their Virginia return for tax years beginning on or after January 1, 2026, which is before that market even opens. We cover the mechanics in our guide to Virginia cannabis taxes and excise rates.
One structural point that is easy to get wrong: if you intend to hold hemp and cannabis operations at the same time, the ownership structure has to be designed for it up front. States that permit dual licensure often condition it on common majority ownership, and states that prohibit it will read a shared parent company as a disqualifying relationship. Restructuring after an application is filed is far harder than structuring correctly before.
Suitability and disclosure
This section covers the risk hemp operators are least prepared for, and it is worth reading carefully even if the rest of your plan is sound.
Cannabis licensing involves suitability review. Applicants disclose ownership, financing sources, criminal history, regulatory history, and prior business conduct — and licensing authorities verify it. For an operator coming out of hemp, three areas draw attention.
- Prior sale of intoxicating hemp products. Some states view a delta-8 or THCA business as legitimate commerce under the prior federal definition. Others treat it as having sold intoxicants outside the regulated system. Know which posture your regulator takes before you draft a narrative around your hemp history.
- Open enforcement matters. Unresolved state civil penalties, seizures, product recalls, or labeling actions on the hemp side surface in review and can delay or sink an application. Resolve what can be resolved and disclose what cannot.
- Capital provenance. Money that came into the hemp business from informal sources, unregistered investors, or offshore accounts is a disclosure problem in cannabis even when it was unremarkable in hemp. Clean the cap table before you file.
The instinct to minimize the hemp history in an application is understandable and usually a mistake. Omissions that surface during verification are treated as misrepresentation, which is far more damaging than the underlying fact would have been. The better approach is to present the hemp operation affirmatively — testing regimes, age-verification practices, labeling standards, recall procedures — as evidence of operating discipline, and to disclose the difficult items plainly with context.
Worth knowing. Well-documented hemp compliance is an asset in a licensing file. If you ran third-party testing with retained certificates of analysis, enforced 21-plus sales, maintained batch records, and can produce a recall procedure you actually followed, that is a credible operating history — and it is scored more favorably than an applicant with no operating history at all. The operators who fare worst are not the ones with a hemp past. They are the ones who cannot document it.
The next ninety days
Between now and the November date, there is a defined set of work that is worth doing regardless of what Congress does. None of it is wasted if the deadline slips.
| Timing | Action |
|---|---|
| Week 1 | Run every SKU against both tests — total THC at 0.3% dry weight, and 0.4 mg total THC per container. Sort the catalog into compliant, reformulable, and dead. Most operators are surprised by how much sits in column three |
| Weeks 1–2 | Confirm your own state's hemp cutoff date and its terms, which may be earlier and stricter than the federal one. Do not rely on a national summary for this |
| Weeks 2–4 | Build the month-by-month cash model across the gap between hemp cutoff and realistic cannabis revenue. Identify how it gets funded |
| Weeks 3–6 | Pick a path. Verify whether your state has a legislated hemp-to-cannabis pathway, when the next license window opens, and whether your existing site is eligible under zoning and buffer rules |
| Weeks 4–8 | Clean the file: resolve open enforcement matters, document the cap table, assemble testing and batch records, and inventory what SOPs exist versus what a licensing authority will expect |
| Weeks 6–12 | Begin the substantive deliverables — business plan, pro forma, security plan, cultivation or manufacturing plan, SOPs written to your state's rules. These take months, not weeks, and cannot be compressed at the deadline |
| Ongoing | Track the federal vehicle — the House schedule after August 31, the appropriations path, and the Barr-Craig framework — but do not let the tracking substitute for the work |
Five mistakes we keep seeing
These come up often enough across engagements to be worth naming directly.
- Waiting for Congress. The delay-and-hope strategy has now cost operators most of a year of preparation time. Even the best legislative outcome produces a regulated market that needs the same work.
- Assuming hemp experience earns credit. In most states it earns none formally. What earns points is documentation, site control, capital, local support, and a plan written to the published rubric.
- Treating the license as the finish line. Between award and first sale sits buildout, seed-to-sale onboarding, staff training, and pre-license inspection. Operators who model revenue from the license date run out of cash before the doors open.
- Reusing hemp SOPs. They will not survive a cannabis inspection. A document set that maps to your state's regulations and tracking system is a build, not a find-and-replace.
- Skipping the exit analysis. Selling or merging is a legitimate outcome, and it is worth more before the revenue stops than after. Getting a valuation costs little and clarifies every other decision.
How Cannaspire helps
Cannaspire's cannabis consultants have supported more than 475 successful license applications for 450+ clients across 35+ states and eight-plus countries since 2019. We work on both sides of this line — hemp and cannabis — which matters here, because a transition engagement is not a licensing project or a compliance project. It is both, running at once, against a date.
On a hemp-to-cannabis engagement, you can expect us to:
- Audit the catalog against both tests. Total THC and per-container, SKU by SKU, sorted into what survives, what can be reformulated, and what has to go. Our team includes analytical and testing specialists who work on hemp-versus-marijuana differentiation and certificate-of-analysis review.
- Choose the path on evidence. Reformulate, apply, supply, or exit — assessed against your capital, your site, your state's rules, and the next realistic license window rather than against optimism.
- Model the gap. A cannabis business plan and pro forma that carry the cutoff-to-revenue gap honestly, with documented assumptions and sensitivity cases a lender or a scorer can follow.
- Rebuild the document set. SOPs, quality manuals, security plans, and training programs written to a specific state's regulations and tracking system, with GMP readiness where the market or a future buyer requires it.
- Prepare the disclosure story. Suitability review, enforcement history, and cap-table cleanup handled deliberately, so the hemp record reads as operating discipline rather than as a problem.
- Stay on after the award. Buildout, pre-license inspection prep, and ongoing fractional compliance so the license survives its first audit.
Where a matter turns into litigation or an enforcement dispute, our cannabis and hemp expert witness team supports attorneys and insurers on testing methodology, chain of custody, and regulatory interpretation. We are consultants, not attorneys or tax advisors — on questions that require a licensed professional we will say so and work alongside yours.
475+ licenses won. Now working with hemp operators making the move.
We are running transition engagements in Virginia, Minnesota, Ohio, New York, and beyond — catalog audit through licensure and buildout. If November is a problem you have not solved yet, start with a conversation.
Schedule a Free ConsultationFrequently asked questions
When does the federal hemp ban take effect?
What is the 0.4 mg per-container limit?
Can a hemp business get a cannabis license?
How long does a hemp to cannabis transition take?
Do my hemp SOPs work for a cannabis license?
Does Section 280E apply if I move from hemp to cannabis?
What happens to my hemp inventory after the deadline?
Is reformulating a realistic alternative to getting a cannabis license?
What is the Lawful Hemp Protection Act?
Should I sell my hemp brand instead of transitioning?
November is closer than a licensing cycle
Whether you are reformulating, preparing a first cannabis application, or weighing an exit, the work starts with an honest read of your catalog, your state, and your runway. Our cannabis licensing team can help you get there. Free 30-minute consultation, no commitment.
Start the ConversationPrimary sources
- P.L. 119-37, Continuing Appropriations and Extensions Act, 2026, Division B, Section 781 (enacted November 12, 2025)
- Congressional Research Service, Changes to the Statutory Definition of Hemp and Issues for Congress (IF13136) and Change to Federal Definition of Hemp and Implications for Federal Enforcement (IN12620)
- Virginia Cannabis Control Authority and Virginia Department of Agriculture and Consumer Services, "Virginia's New Marijuana and Hemp Laws: What You Need to Know" (July 2026)
- Minnesota Office of Cannabis Management, 2026 legislative changes to Minnesota Statutes Chapter 342 (SF 4401)
- MJBizDaily reporting on the Lawful Hemp Protection Act (July 22, 2026) and the Senate's temporary extension of the hemp THC deadline (August 10, 2026)
Disclaimer: This article describes the federal hemp definition enacted at Section 781 of P.L. 119-37 and selected state frameworks as of August 2026, and is a fast-moving subject. At publication, the November 12, 2026 effective date remained operative; Senate-passed language extending it had not become law, and the House had not acted. Federal legislative vehicles, FDA guidance, agency enforcement posture, and state hemp and cannabis rules are all subject to change, and several state matters referenced here are in active litigation. Nothing here is legal, tax, or investment advice, does not create a client relationship, and should not be relied upon in place of advice from a qualified attorney or tax advisor regarding your specific facts. Cannaspire is a cannabis and hemp consulting firm and does not practice law or provide tax opinions. Last updated: August 10, 2026.